Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q3 EPS of ($0.95), $0.02 better than the analyst estimate of ($0.97).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.